Compare GHM & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHM | ARDX |
|---|---|---|
| Founded | 1936 | 2007 |
| Country | United States | United States |
| Employees | 732 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 1994 | 2014 |
| Metric | GHM | ARDX |
|---|---|---|
| Price | $109.77 | $6.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $73.33 | $15.14 |
| AVG Volume (30 Days) | 271.8K | ★ 3.3M |
| Earning Date | 06-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.90 | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $245,293,000.00 | $2,607,000.00 |
| Revenue This Year | $14.54 | $37.75 |
| Revenue Next Year | $18.23 | $34.24 |
| P/E Ratio | $96.35 | ★ N/A |
| Revenue Growth | ★ 16.86 | N/A |
| 52 Week Low | $46.08 | $3.74 |
| 52 Week High | $119.04 | $8.40 |
| Indicator | GHM | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 58.03 | 57.43 |
| Support Level | $88.46 | $5.46 |
| Resistance Level | N/A | $6.23 |
| Average True Range (ATR) | 7.43 | 0.27 |
| MACD | 0.57 | 0.09 |
| Stochastic Oscillator | 72.23 | 78.88 |
Graham Corp designs and manufactures mission-critical fluid, power, heat transfer, vacuum, and mixing technologies for the Defense, Energy & Process, and Space industries. In Defense, its equipment is used in nuclear and non-nuclear propulsion, power, fluid transfer, thermal management, and mixing systems. In Energy & Process industries, it supplies equipment for vacuum, heat transfer, mixing, and fluid transfer applications used in oil refining, chemical facilities, fertilizers, ethylene, methanol, energetics, food & beverage, medical, and alternative energy applications such as hydrogen and geothermal processes. In the Space industry, its equipment is used in propulsion, power, thermal management, mixing, and life support systems. It operates in the United States and other countries.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.